CellRapeutics™ Leukopak from CIDP Donor (XS-0426-XU274)

Name: CellRapeutics™ Leukopak from CIDP Donor
SKU: XS-0426-XU274
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Sourced from donors with Chronic Inflammatory Demyelinating Polyneuropathy, this Leukopak provides a specialized pool of cells involved in peripheral nerve demyelination. The leucocyte population is characterized by dysregulated T-cell and B-cell responses targeting myelin-associated glycoproteins. This product is critical for research into the pathogenesis of chronic autoimmune neuropathies and the discovery of circulating biomarkers for treatment response in CIDP.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from CIDP Donor

Cat. No.
XS-0426-XU274

Donor Age
Middle-Aged, Senior

Donor Health
Diagnosed with Chronic Inflammatory Demyelinating Polyneuropathy. The leukocyte profile reflects a sustained immune-mediated attack on peripheral nerves, featuring specific pro-inflammatory T-cell and macrophage signatures.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, prioritized to maintain the viability of myelin-reactive T cells and peripheral nerve-homing lymphocytes.

Additional Donor Information
Each lot features a Leukopak from donors with Chronic Inflammatory Demyelinating Polyneuropathy. Profiles include neurological disability scores and history of intravenous immunoglobulin or plasma exchange therapy.

Clinical Profile
Disease course, electrodiagnostic findings, and history of IVIG, plasma exchange, or corticosteroid treatments.

Additional Information

Medication History
Available upon request. Records of intravenous immunoglobulin, corticosteroids, and history of plasma exchange or immunosuppressive maintenance.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from CIDP Donor, Leukopak, CIDP

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from CIDP Donor (XS-0426-XU274). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.